Dutch industry magazine Biotech NEWS and Life Sciences has profiled CR2O in their 2020 Winter edition.
Biotech NEWS and Life Sciences is a national magazine reporting on trends and news within health and life sciences in The Netherlands. During the interview with CR2O, management team members Cari, Ellemieke, and Nick explain how CR2O has seen considerable growth over the past years, and why CR2O is an early phase clinical trial expert that is ‘big enough to deliver, small enough to care’.
To read the full article and learn more on CR2O’s background, recent clinical trials, and core expertise, you can find the November edition of Biotech News and Life Sciences magazine by clicking here.